Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study).
| Image |  |
|---|---|
| Description | scientific article published on 28 July 2016 |
| Author/s |
author: Kazuhiro Yoshida Takao Takahashi |
| Publication date | July 28, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |